Medeon Biodesign Inc Share Price Taipei Exchange
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
05-10 | Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-08 | Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 298M 9.21M 0 723M | Sales 2023 | 196M 6.06M 0 476M | Capitalization | 4.29B 133M 0 10.41B |
---|---|---|---|---|---|
Net income 2022 | -434M -13.4M - -1.05B | Net income 2023 | -1.2B -37.19M - -2.92B | EV / Sales 2022 | 12.5 x |
Net cash position 2022 | 1.35B 41.62M 0 3.27B | Net cash position 2023 | 1.96B 60.35M 0 4.74B | EV / Sales 2023 | 11.9 x |
P/E ratio 2022 |
-11.7
x | P/E ratio 2023 |
-3.56
x | Employees | - |
Yield 2022 |
0.86% | Yield 2023 |
-
| Free-Float | 47.57% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 21/12/12 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 21/12/12 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 19/04/15 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 13/01/14 |
1st Jan change | Capi. | |
---|---|---|
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |